EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Recombinant ADAMTS-13 Improves Survival of Mice Subjected to Endotoxemia

Daniel Gao, Zhou Zhou, Ruidong Ma, Huaizhu Wu, Trung Nguyen, Li Liu, Jingfei Dong iD

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms241411782 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Daniel Gao und 6 weiteren Autor:innen. Beteiligte Einrichtung: Bloodworks Research Institute, Seattle, WA 98102, USA. Hauptthemen laut MEDLINE: ADAM Proteins, Endotoxemia. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIDDK NIH HHS, NHLBI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

When stimulated by proinflammatory mediators, endothelial cells release ultra-large von Willebrand factor (ULVWF) multimers that are hyperactive in activating and aggregating platelets. These ULVWF multimers can accumulate in the circulation and on the inflamed endothelium because they are insufficiently cleaved by the metalloprotease ADAMTS-13, which becomes moderately deficient under conditions of systemic inflammation. This moderate ADAMTS-13 deficiency may lead to thrombotic complications that contribute to ischemic tissue injury and organ failure that are associated with severe infections. To test this hypothesis, we investigated whether recombinant ADAMTS-13 improves the pathological course of endotoxemia in lipopolysaccharide (LPS)-treated mice. C57BL/J6 mice received a bolus infusion of either 5 µg/mouse of ADAMTS-13 or vehicle control 30 min after LPS challenge and were monitored for seven-day survival. During the monitoring period, platelet counts, VWF antigen, and ADAMTS-13 activity were measured. Thrombosis was also examined by the immunohistochemistry in the liver. We found that ADAMTS-13 reduced mortality from 66% to 34.9%. The improved survival was associated with a greater recovery from thrombocytopenia, higher plasma ADAMTS-13 activity, and less thrombotic vascular occlusion. These results suggest that systemic inflammation could result in deficient ULVWF proteolysis by ADAMTS-13 and that ADAMTS-13 improves the outcomes of endotoxemia-induced inflammation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ADAM ProteinsEndotoxemiaAnimalsMiceEndothelial CellsADAMTS13 ProteinLipopolysaccharidesMice, Inbred C57BLvon Willebrand Factor

Stichwörter der Autor:innen

ADAMTS-13endotheliopathyendotoxemiaplateletsvon Willebrand factor

Substanzen

ADAM ProteinsADAMTS13 ProteinLipopolysaccharidesvon Willebrand Factor

Autor:innen und Institutionen

  • Bloodworks Research Institute, Seattle, WA 98102, USA.
  • Department of Chemistry, Pomona College, Claremont, CA 91711, USA.
  • Cardiovascular Sciences, Department of Medicine, Baylor College of Medicine, Houston, TX 77030, USA.
  • Division of Critical Care Medicine, Department of Pediatrics, Baylor College of Medicine, Houston, TX 77030, USA.
  • Center for Translational Research on Inflammatory Diseases at the Michael E. DeBakey Veteran Administration Medical Center, Houston, TX 77030, USA.
  • Tianjin Neurology Research Institute, Tianjin Medical University General Hospital, Tianjin 300052, China.

ORCID-Profile: Jingfei Dong

Förderung

  • NIA NIH HHS
  • NIDDK NIH HHS
  • NHLBI NIH HHS
  • NIH HHS
  • NIH

Zitieren

APA

Gao, D., Zhou, Z., Ma, R., Wu, H., Nguyen, T., Liu, L., & Dong, J. (2023). Recombinant ADAMTS-13 Improves Survival of Mice Subjected to Endotoxemia. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms241411782

Vancouver

Gao D, Zhou Z, Ma R, Wu H, Nguyen T, Liu L, et al. Recombinant ADAMTS-13 Improves Survival of Mice Subjected to Endotoxemia. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms241411782

BibTeX
@article{Gao2023,
  author = {Gao, Daniel and Zhou, Zhou and Ma, Ruidong and Wu, Huaizhu and Nguyen, Trung and Liu, Li and Dong, Jingfei},
  title = {Recombinant ADAMTS-13 Improves Survival of Mice Subjected to Endotoxemia},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms241411782}
}
Kostenlos starten →